Subclinical disease as an independent risk factor for cardiovascular disease.

BACKGROUND The primary aim of the present study was to determine the relation between measures of subclinical cardiovascular disease and the incidence of clinical cardiovascular disease among 5201 adults 65 years of age or older who were participating in the Cardiovascular Health Study. METHODS AND RESULTS A new method of classifying subclinical disease at baseline examination in the Cardiovascular Health Study included measures of ankle-brachial blood pressure, carotid artery stenosis and wall thickness, ECG and echocardiographic abnormalities, and positive response to the Rose Angina and Claudication Questionnaire. Participants were followed for an average of 2.39 years (maximum, 3 years). For participants without evidence of clinical cardiovascular disease at baseline, the presence of subclinical disease compared with no subclinical disease was associated with a significant increased risk of incident total coronary heart disease including CHD deaths and nonfatal MI and angina pectoris for both men and women. For individuals with subclinical disease, the increased risk of total coronary heart disease was 2.0 for men and 2.5 for women, and the increased risk of total mortality was 2.9 for men and 1.7 for women. The increased risk changed little after adjustment for other risk factors, including lipoprotein levels, blood pressure, smoking, and diabetes. CONCLUSIONS The measurement of subclinical disease provides an approach for identifying high-risk older individuals who may be candidates for more active intervention to prevent clinical disease.

[1]  J. Salonen,et al.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  A. Hofman,et al.  Cigarette Smoking and the Development and Progression of Aortic Atherosclerosis A 9‐Year Population‐Based Follow‐up Study in Women , 1993, Circulation.

[3]  L. Kuller,et al.  Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. , 1993, JAMA.

[4]  L H Kuller,et al.  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. , 1991, American journal of epidemiology.

[5]  W. L. Ooi,et al.  Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.

[6]  J. Gardin,et al.  Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. , 1994, American journal of epidemiology.

[7]  I. Holme,et al.  An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. , 1990, Circulation.

[8]  S. Wannamethee,et al.  Risk Factors and Cardiovascular Outcome , 1991 .

[9]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[10]  J. Polak,et al.  Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. , 1993, Circulation.

[11]  D. Levy,et al.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.

[12]  R. Kronmal,et al.  Prevalence of cardiovascular diseases among older adults : the cardiovascular health study , 1993 .

[13]  L. Kuller,et al.  Blood Pressure Treatment Slows the Progression of Carotid Stenosis in Patients With Isolated Systolic Hypertension , 1994, Stroke.

[14]  L. Kuller,et al.  Decreased ankle/arm blood pressure index and mortality in elderly women. , 1993, JAMA.

[15]  B M Psaty,et al.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.

[16]  Vesa Manninen,et al.  Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.

[17]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[18]  L. Fried,et al.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[19]  L. Pourcelot,et al.  STROKE RISK IN PATIENTS WITH CAROTID STENOSIS , 1987, The Lancet.

[20]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[21]  M. Criqui.  Cholesterol, primary and secondary prevention, and all-cause mortality. , 1991, Annals of internal medicine.

[22]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[23]  S. Thompson,et al.  Prothrombin Activation Fragment 1 + 2 and Thrombin Antithrombin III Complexes in Patients with Angina Pectoris: Relation to the Presence and Severity of Coronary Atherosclerosis , 1993, Thrombosis and Haemostasis.

[24]  W. Roberts,et al.  Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. , 1992, The American journal of cardiology.

[25]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[26]  W. Aronow,et al.  Forty‐five-month follow‐up of extracranial carotid arterial disease for new coronary events in elderly patients , 1992 .

[27]  M. Alderman,et al.  Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events , 1993, Circulation.

[28]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[29]  B. Psaty,et al.  Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. , 1992, The American journal of cardiology.

[30]  H. S. Klopfenstein,et al.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[32]  C. Ruckley.  Symptomatic and Asymptomatic Disease , 1991 .

[33]  L. Kuller.  AHA symposium/epidemiology meeting: Atherosclerosis. Discussion: Why measure atherosclerosis? , 1993, Circulation.

[34]  J. Toole,et al.  Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. , 1990, Circulation.

[35]  W. Kannel,et al.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[36]  P. Wolf,et al.  Cholesterol and carotid atherosclerosis in older persons: the Framingham Study. , 1992, Annals of epidemiology.

[37]  G. Rose,et al.  Self-administration of a questionnaire on chest pain and intermittent claudication. , 1977, British journal of preventive & social medicine.

[38]  A. G. Shaper,et al.  Calf pain on walking, risk factors and cardiovascular outcome in middle-aged British men , 1991 .

[39]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.